Point72 Asset Management Portfolio holdings
AUM
$42.3B
1-Year Return
23.07%
This Quarter Return
+11.82%
1 Year Return
+23.07%
3 Year Return
+96.14%
5 Year Return
+182.48%
10 Year Return
+383.75%
AUM
$33B
AUM Growth
+$3.68B
(+13%)
Cap. Flow
-$46.1M
Cap. Flow
% of AUM
-0.14%
Top 10 Holdings %
Top 10 Hldgs %
9.78%
Holding
2,289
New
411
Increased
470
Reduced
375
Closed
792
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$263M |
| 2 |
Oracle
ORCL
|
$230M |
| 3 |
Thermo Fisher Scientific
TMO
|
$225M |
| 4 |
RH
RH
|
$174M |
| 5 |
Evergy
EVRG
|
$172M |
Top Sells
| 1 |
Microsoft
MSFT
|
$590M |
| 2 |
NVIDIA
NVDA
|
$539M |
| 3 |
Boeing
BA
|
$266M |
| 4 |
Intel
INTC
|
$208M |
| 5 |
Arista Networks
ANET
|
$206M |
Sector Composition
| 1 | Healthcare | 18.68% |
| 2 | Technology | 17.01% |
| 3 | Consumer Discretionary | 13.87% |
| 4 | Industrials | 13.32% |
| 5 | Energy | 7.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
KKR & Co
KKR
$122B
| $67.3M | 0.16% |
812,680
-810,920
| -50% | -$67.2M |
|
152
Corteva
CTVA
$49.3B
| $67.2M | 0.16% |
1,401,608
+351,908
| +34% | +$16.9M |
|
|
WBA
153
DELISTED
Walgreens Boots Alliance
WBA
| $67.1M | 0.16% |
+2,568,271
| New | +$67.1M |
|
154
Credo Technology Group
CRDO
$23.2B
| $67M | 0.16% |
3,443,708
-1,379,592
| -29% | -$26.9M |
|
155
Invesco
IVZ
$9.79B
| $67M | 0.16% |
3,756,500
+3,507,900
| +1,411% | +$62.6M |
|
156
Axsome Therapeutics
AXSM
$6.21B
| $66.6M | 0.16% |
837,201
+305,264
| +57% | +$24.3M |
|
157
Fidelity National Information Services
FIS
$35.9B
| $66.6M | 0.16% |
1,108,809
+388,134
| +54% | +$23.3M |
|
158
Adobe
ADBE
$146B
| $66.6M | 0.16% |
111,572
+50,994
| +84% | +$30.4M |
|
159
Carlisle Companies
CSL
$16.8B
| $65.8M | 0.16% |
210,635
-47,689
| -18% | -$14.9M |
|
160
First Citizens BancShares
FCNCA
$26B
| $65.5M | 0.16% |
46,180
+26,107
| +130% | +$37M |
|
161
Air Products & Chemicals
APD
$64.5B
| $65.2M | 0.16% |
238,170
-94,645
| -28% | -$25.9M |
|
162
Qiagen
QGEN
$10.2B
| $64.4M | 0.16% |
1,398,334
-2,731,041
| -66% | -$126M |
|
163
Imperial Oil
IMO
$44.5B
| $63.9M | 0.15% |
1,120,229
+293,910
| +36% | +$16.8M |
|
164
Travelers Companies
TRV
$62.9B
| $63.6M | 0.15% |
333,854
+331,127
| +12,143% | +$63.1M |
|
165
Vistra
VST
$64.3B
| $63.3M | 0.15% |
1,643,300
+551,796
| +51% | +$21.3M |
|
166
Option Care Health
OPCH
$4.67B
| $62.8M | 0.15% |
1,864,477
+1,648,537
| +763% | +$55.5M |
|
167
Molson Coors Class B
TAP
$9.87B
| $62.5M | 0.15% |
1,021,371
-67,334
| -6% | -$4.12M |
|
168
Delta Air Lines
DAL
$39.5B
| $62.2M | 0.15% |
1,546,164
+1,352,120
| +697% | +$54.4M |
|
169
Okta
OKTA
$15.8B
| $61.8M | 0.15% |
+682,900
| New | +$61.8M |
|
170
Syndax Pharmaceuticals
SNDX
$1.39B
| $61.3M | 0.15% |
2,834,499
+740,298
| +35% | +$16M |
|
|
CBAY
171
DELISTED
Cymabay Therapeutics
CBAY
| $60.8M | 0.15% |
2,573,700
+143,776
| +6% | +$3.4M |
|
172
Masimo
MASI
$7.77B
| $60.5M | 0.15% |
516,356
+329,712
| +177% | +$38.6M |
|
173
Entegris
ENTG
$12.1B
| $60.1M | 0.15% |
501,895
+476,495
| +1,876% | +$57.1M |
|
174
Protagonist Therapeutics
PTGX
$3.71B
| $59.9M | 0.14% |
2,613,453
+1,505,313
| +136% | +$34.5M |
|
175
Roblox
RBLX
$90B
| $59.8M | 0.14% |
1,308,417
+684,439
| +110% | +$31.3M |
|